Skip to main content
. 2019 Nov 28;183(1):39–51. doi: 10.1111/bjd.18565

Figure 4.

Figure 4

Efficacy outcomes in the Japanese cohort from SOLO 1, including the proportions of patients with ≥ 4‐point improvement in (a) Patient‐Oriented Eczema Measure (POEM) and (b) Dermatology Life Quality Index (DLQI) over time. Values after the first rescue treatment used were set to missing (censoring). POEM and DLQI analyses were performed in the subgroup of patients with respective baseline scores ≥ 4. LS, least squares; qw, weekly; q2w, every 2 weeks.